An overview on microglial origin, distribution, and phenotype in Alzheimer's disease

Rezwanul Islam1, Hadi Choudhary1, Robin Rajan2

  • 1Department of Biomedical Sciences, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida, USA.

Insights

Microglia, the brain's immune cells, play a dual role in Alzheimer's disease (AD) progression. Understanding their inflammatory and phagocytic functions is key to developing new AD treatments.

Area of Science:

  • Neuroscience
  • Immunology
  • Genetics

Background:

  • Alzheimer's disease (AD) is a leading cause of dementia, linked to amyloid-beta (Ab) plaque deposition.
  • Microglia, brain-resident macrophages, are increasingly implicated in AD pathogenesis.
  • Elevated inflammatory markers in AD patients suggest a role for neuroinflammation.

Purpose of the Study:

  • To review the multifaceted roles of microglia in Alzheimer's disease.
  • To explore the impact of microglia-specific genes on AD progression.
  • To elucidate the contribution of neuroinflammation to AD.

Main Methods:

  • Review of existing literature on microglia and Alzheimer's disease.
  • Analysis of genetic studies linking microglia to AD risk.
  • Examination of neuroinflammation markers and their correlation with AD.

Main Results:

  • Microglia exhibit diverse activation states influencing neuroinflammation.
  • Microglia can mediate both protective and detrimental effects on neurons.
  • Numerous AD risk genes are expressed in microglia, highlighting their central role.

Conclusions:

  • Microglia are critical players in Alzheimer's disease, with complex roles in neuroinflammation and neuronal health.
  • Targeting microglial activation pathways may offer therapeutic strategies for AD.
  • Further research into microglia-specific genes is essential for understanding AD progression.